Igm Biosciences, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
March 07, 2024 at 09:10 pm
IGM Biosciences, Inc. reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported net loss was USD 60.7 million compared to USD 52.58 million a year ago. Basic loss per share from continuing operations was USD 1.01 compared to USD 1.19 a year ago.
For the full year, the company reported net loss was USD 246.42 million compared to USD 221.1 million a year ago. Basic loss per share from continuing operations was USD 4.71 compared to USD 5.32 a year ago.